Zhu Zhen-Zhen, Hao Hong-Xing, Tao Rui, Zhang Yi-Wen
Three Departments of Respiration Medicine, Anhui Provincial Chest Hospital & Anhui Medical University Clinical College of Chest, Hefei, China.
J Thorac Dis. 2024 Nov 30;16(11):7310-7319. doi: 10.21037/jtd-24-831. Epub 2024 Nov 14.
The morbidity and mortality of chronic pulmonary aspergillosis (CPA) are very high. We aimed to investigate the prognostic factors of patients with CPA, especially focusing on the underlying pulmonary disease and the probable co-infection of bacterial.
We retrospectively analyzed 106 CPA patients from November 2019 to August 2023. We collected the patient's clinical medical records. Kaplan-Meier survival curves were used to analyze patient survival; log-rank tests were utilized to compare survival among groups. Univariate and multivariate Cox proportional hazards regression analyses were applied for identification of potential prognostic factors.
The mean age at the time of diagnosis was 60.3±14.8 years; 74 (69.8%) patients were male. There was significant difference between patients with and without lung cancer (P<0.001), and with and without emphysema (P=0.02). Other prognosis factors associated with mortality were as follows: smoking (P=0.04), cough (P=0.01), simultaneous discovery with Gram-negative bacteria (P=0.02), and hypoalbuminemia (P=0.001) in log-rank tests. Multivariate Cox regression analyses showed that emphysema [hazard ratio (HR), 4.107; 95% confidence interval (CI): 1.414-11.933; P=0.009] and lung cancer (HR, 8.511; 95% CI: 2.494-29.047; P<0.001) were identified as independent predictors of mortality. The 1- and 3-year survival rates with emphysema were 75.2% and 64.9%, respectively, whereas those for patients without emphysema were 92.6% and 85.9%, respectively.
In the current study, emphysema and lung cancer were independent predictors of mortality. Therefore, we should pay attention to the patients with these underlying lung diseases in order to improve the prognosis.
慢性肺曲霉病(CPA)的发病率和死亡率很高。我们旨在研究CPA患者的预后因素,尤其关注潜在的肺部疾病以及可能的细菌合并感染。
我们回顾性分析了2019年11月至2023年8月期间的106例CPA患者。我们收集了患者的临床病历。采用Kaplan-Meier生存曲线分析患者生存率;运用对数秩检验比较各组间的生存率。应用单因素和多因素Cox比例风险回归分析来识别潜在的预后因素。
诊断时的平均年龄为60.3±14.8岁;74例(69.8%)患者为男性。有肺癌和无肺癌患者之间(P<0.001)以及有肺气肿和无肺气肿患者之间(P=0.02)存在显著差异。对数秩检验中,与死亡率相关的其他预后因素如下:吸烟(P=0.04)、咳嗽(P=0.01)、同时发现革兰氏阴性菌(P=0.02)和低白蛋白血症(P=0.001)。多因素Cox回归分析显示,肺气肿[风险比(HR),4.107;95%置信区间(CI):1.414-11.933;P=0.009]和肺癌(HR,8.511;95%CI:2.494-29.047;P<0.001)被确定为死亡率的独立预测因素。有肺气肿患者的1年和3年生存率分别为75.2%和64.9%,而无肺气肿患者的1年和3年生存率分别为92.6%和85.9%。
在本研究中,肺气肿和肺癌是死亡率的独立预测因素。因此,为改善预后,我们应关注患有这些潜在肺部疾病的患者。